TABLE 1.
Patient characteristics, embryo quality, and fertility in groups with low and high apoB concentration in FF
All Patients |
Patients Without Direct Ovarian Disorders |
|||||
---|---|---|---|---|---|---|
ApoB (mg/L) |
ApoB (mg/L) |
|||||
Low (≤13.6) (n = 14) | High (>13.6) (n = 13) | P | Low (≤13.6) (n = 9) | High (>13.6) (n = 9) | P | |
Age | 35.3 ± 3.5 | 33.6 ± 4.7 | 0.366 | 34.8 ± 3.3 | 34.2 ± 5.9 | 0.832 |
BMI | 21.2 ± 2.1 | 21.3 ± 3.8 | 0.417 | 22.2 ± 1.8 | 22.0 ± 4.6 | 0.647 |
IVF/ICSI (n) | 8 / 6 | 7 / 6 | 0.863 | 5 / 4 | 4 / 5 | 0.637 |
ApoB (mg/L) | 11.6 ± 0.8 | 16.6 ± 2.5 | <0.0001 | 11.5 ± 0.7 | 16.4 ± 3.0 | 0.009 |
Top-quality embryos (n) | 2.2 ± 2.8 | 3.0 ± 2.5 | 0.174 | 1.2 ± 1.3 | 4.0 ± 1.6 | 0.027 |
Grade 4 embryos (n) | 1.6 ± 2.7 | 2.8 ± 2.2 | 0.034 | 0.6 ± 0.9 | 3.6 ± 1.5 | 0.011 |
Clinical pregnancy rate (%) | 23.1 | 69.2 | 0.013 | 0.0 | 60.0 | 0.038 |
Continuous variables are means ± SD and were compared using Mann-Whitney U-test. Distribution of fertilization methods (IVF and ICSI) and clinical pregnancy data were compared by the chi-square test. BMI, body mass index. Boldface type indicates significant differences between low and high apoB groups.